Galderma Group AG (VIE:GALD)

Austria flag Austria · Delayed Price · Currency is EUR
160.00
-1.00 (-0.62%)
At close: Mar 3, 2026
Market Cap 38.45B
Revenue (ttm) 3.99B
Net Income (ttm) 321.87M
Shares Out n/a
EPS (ttm) 1.35
PE Ratio 119.45
Forward PE 45.48
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 16
Open 159.00
Previous Close 161.00
Day's Range 159.00 - 160.00
52-Week Range 149.00 - 180.00
Beta n/a
RSI 45.49
Earnings Date Mar 5, 2026

About Galderma Group AG

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes ACTINICA, Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, Mirvaso, NEMLUVIO, Relfydess, Benzac, Loceryl, and TRI-LUMA in therapeutic dermatology. ... [Read more]

Industry Pharmaceutical Preparations
Founded 1981
Country Switzerland
Stock Exchange Vienna Stock Exchange
Ticker Symbol GALD
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.